Therefore, we hypothesized that regulatory HLA-E epitopes, specifically located in the myelin sheath, were present and that immunization with such myelin-specific HLA-E epitopes activated the epitope-specific HLA-E-restricted CD8+ Treg cells to ameliorate MS. The gene discussed is CD8A; the disease is myeloid sarcoma.